<root>
	<PMID Version="1">25568664</PMID>
	<Summary>
		1: Oancea C, RÃ¼ster B, Brill B, Roos J, Heinssmann M, Bug G, Mian AA, Guillen NA,Kornblau SM, Henschler R, Ruthardt M. STAT activation status differentiatesleukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenicin t(6;9)-positive AML. Genes Cancer. 2014 Nov;5(11-12):378-92. PubMed PMID:25568664; PubMed Central PMCID: PMC4279436.
	</Summary>
</root>
